Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy

P. Ghiorzo, V. Pensotti, G. Fornarini, S. Sciallero, L. Battistuzzi, F. Belli, L. Bonelli, G. Borgonovo, W. Bruno, A. Gozza, S. Gargiulo, L. Mastracci, S. Nasti, G. Palmieri, F. Papadia, L. Pastorino, A. Russo, V. Savarino, L. Varesco, L. BernardG. Bianchi Scarrà

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Pancreatic adenocarcinoma (PC) is the third most common cancer associated with BRCA mutations. Most notice has been given to BRCA2, while the association between BRCA1 and PC is less widely reported. Recently, PALB2 has been implicated in both PC and breast cancer (BC) susceptibility. We selected 29 Italian PC patients from a case-control study of PC according to their personal and family history of both PC and breast/ovarian cancer (BC/OC) and tested them for presence of germline mutations in BRCA1, BRCA2 and PALB2. We identified no germline mutations or deletions in PALB2, but detected 7 BRCA mutations (4 in BRCA1 and 3 in BRCA2). These findings suggest that PALB2 does not play a major role in PC susceptibility in our population. As we found an almost equal frequency of germline mutations in BRCA1 and BRCA2, germline alterations in either of these genes may explain a subset of Italian families presenting both PC and BC/OC. Moreover, as we began the observation of these families from probands who are affected by PC, we provide here a direct assessment of the role of PALB2 and BRCA mutations in PC susceptibility.

Original languageEnglish
Pages (from-to)41-47
Number of pages7
JournalFamilial Cancer
Volume11
Issue number1
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Germ-Line Mutation
Pancreatic Neoplasms
Italy
Adenocarcinoma
Genes
Breast Neoplasms
Mutation
Ovarian Neoplasms
Case-Control Studies
Observation

Keywords

  • BRCA
  • Germline mutation
  • Hereditary breast ovarian cancer syndrome (HBOC)
  • PALB2
  • Pancreatic cancer susceptibility

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Oncology
  • Genetics(clinical)

Cite this

Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. / Ghiorzo, P.; Pensotti, V.; Fornarini, G.; Sciallero, S.; Battistuzzi, L.; Belli, F.; Bonelli, L.; Borgonovo, G.; Bruno, W.; Gozza, A.; Gargiulo, S.; Mastracci, L.; Nasti, S.; Palmieri, G.; Papadia, F.; Pastorino, L.; Russo, A.; Savarino, V.; Varesco, L.; Bernard, L.; Bianchi Scarrà, G.

In: Familial Cancer, Vol. 11, No. 1, 03.2012, p. 41-47.

Research output: Contribution to journalArticle

Ghiorzo, P, Pensotti, V, Fornarini, G, Sciallero, S, Battistuzzi, L, Belli, F, Bonelli, L, Borgonovo, G, Bruno, W, Gozza, A, Gargiulo, S, Mastracci, L, Nasti, S, Palmieri, G, Papadia, F, Pastorino, L, Russo, A, Savarino, V, Varesco, L, Bernard, L & Bianchi Scarrà, G 2012, 'Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy', Familial Cancer, vol. 11, no. 1, pp. 41-47. https://doi.org/10.1007/s10689-011-9483-5
Ghiorzo, P. ; Pensotti, V. ; Fornarini, G. ; Sciallero, S. ; Battistuzzi, L. ; Belli, F. ; Bonelli, L. ; Borgonovo, G. ; Bruno, W. ; Gozza, A. ; Gargiulo, S. ; Mastracci, L. ; Nasti, S. ; Palmieri, G. ; Papadia, F. ; Pastorino, L. ; Russo, A. ; Savarino, V. ; Varesco, L. ; Bernard, L. ; Bianchi Scarrà, G. / Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. In: Familial Cancer. 2012 ; Vol. 11, No. 1. pp. 41-47.
@article{763134a35e904fb69477a633734dda59,
title = "Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy",
abstract = "Pancreatic adenocarcinoma (PC) is the third most common cancer associated with BRCA mutations. Most notice has been given to BRCA2, while the association between BRCA1 and PC is less widely reported. Recently, PALB2 has been implicated in both PC and breast cancer (BC) susceptibility. We selected 29 Italian PC patients from a case-control study of PC according to their personal and family history of both PC and breast/ovarian cancer (BC/OC) and tested them for presence of germline mutations in BRCA1, BRCA2 and PALB2. We identified no germline mutations or deletions in PALB2, but detected 7 BRCA mutations (4 in BRCA1 and 3 in BRCA2). These findings suggest that PALB2 does not play a major role in PC susceptibility in our population. As we found an almost equal frequency of germline mutations in BRCA1 and BRCA2, germline alterations in either of these genes may explain a subset of Italian families presenting both PC and BC/OC. Moreover, as we began the observation of these families from probands who are affected by PC, we provide here a direct assessment of the role of PALB2 and BRCA mutations in PC susceptibility.",
keywords = "BRCA, Germline mutation, Hereditary breast ovarian cancer syndrome (HBOC), PALB2, Pancreatic cancer susceptibility",
author = "P. Ghiorzo and V. Pensotti and G. Fornarini and S. Sciallero and L. Battistuzzi and F. Belli and L. Bonelli and G. Borgonovo and W. Bruno and A. Gozza and S. Gargiulo and L. Mastracci and S. Nasti and G. Palmieri and F. Papadia and L. Pastorino and A. Russo and V. Savarino and L. Varesco and L. Bernard and {Bianchi Scarr{\`a}}, G.",
year = "2012",
month = "3",
doi = "10.1007/s10689-011-9483-5",
language = "English",
volume = "11",
pages = "41--47",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy

AU - Ghiorzo, P.

AU - Pensotti, V.

AU - Fornarini, G.

AU - Sciallero, S.

AU - Battistuzzi, L.

AU - Belli, F.

AU - Bonelli, L.

AU - Borgonovo, G.

AU - Bruno, W.

AU - Gozza, A.

AU - Gargiulo, S.

AU - Mastracci, L.

AU - Nasti, S.

AU - Palmieri, G.

AU - Papadia, F.

AU - Pastorino, L.

AU - Russo, A.

AU - Savarino, V.

AU - Varesco, L.

AU - Bernard, L.

AU - Bianchi Scarrà, G.

PY - 2012/3

Y1 - 2012/3

N2 - Pancreatic adenocarcinoma (PC) is the third most common cancer associated with BRCA mutations. Most notice has been given to BRCA2, while the association between BRCA1 and PC is less widely reported. Recently, PALB2 has been implicated in both PC and breast cancer (BC) susceptibility. We selected 29 Italian PC patients from a case-control study of PC according to their personal and family history of both PC and breast/ovarian cancer (BC/OC) and tested them for presence of germline mutations in BRCA1, BRCA2 and PALB2. We identified no germline mutations or deletions in PALB2, but detected 7 BRCA mutations (4 in BRCA1 and 3 in BRCA2). These findings suggest that PALB2 does not play a major role in PC susceptibility in our population. As we found an almost equal frequency of germline mutations in BRCA1 and BRCA2, germline alterations in either of these genes may explain a subset of Italian families presenting both PC and BC/OC. Moreover, as we began the observation of these families from probands who are affected by PC, we provide here a direct assessment of the role of PALB2 and BRCA mutations in PC susceptibility.

AB - Pancreatic adenocarcinoma (PC) is the third most common cancer associated with BRCA mutations. Most notice has been given to BRCA2, while the association between BRCA1 and PC is less widely reported. Recently, PALB2 has been implicated in both PC and breast cancer (BC) susceptibility. We selected 29 Italian PC patients from a case-control study of PC according to their personal and family history of both PC and breast/ovarian cancer (BC/OC) and tested them for presence of germline mutations in BRCA1, BRCA2 and PALB2. We identified no germline mutations or deletions in PALB2, but detected 7 BRCA mutations (4 in BRCA1 and 3 in BRCA2). These findings suggest that PALB2 does not play a major role in PC susceptibility in our population. As we found an almost equal frequency of germline mutations in BRCA1 and BRCA2, germline alterations in either of these genes may explain a subset of Italian families presenting both PC and BC/OC. Moreover, as we began the observation of these families from probands who are affected by PC, we provide here a direct assessment of the role of PALB2 and BRCA mutations in PC susceptibility.

KW - BRCA

KW - Germline mutation

KW - Hereditary breast ovarian cancer syndrome (HBOC)

KW - PALB2

KW - Pancreatic cancer susceptibility

UR - http://www.scopus.com/inward/record.url?scp=84858293392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858293392&partnerID=8YFLogxK

U2 - 10.1007/s10689-011-9483-5

DO - 10.1007/s10689-011-9483-5

M3 - Article

C2 - 21989927

AN - SCOPUS:84858293392

VL - 11

SP - 41

EP - 47

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 1

ER -